Your browser doesn't support javascript.
loading
Efficacy studies on a canarypox-rabies recombinant virus.
Taylor, J; Trimarchi, C; Weinberg, R; Languet, B; Guillemin, F; Desmettre, P; Paoletti, E.
Affiliation
  • Taylor J; Virogenetics Corporation, Troy, New York 12180.
Vaccine ; 9(3): 190-3, 1991 Mar.
Article in En | MEDLINE | ID: mdl-2042391
Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge in a number of non-avian species. This report describes the development of a canarypox-rabies recombinant. A comparison is made of the protective efficacy of this recombinant with other pox-rabies recombinants.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Poxviridae / Rabies / Rabies virus / Viral Vaccines Limits: Animals Language: En Journal: Vaccine Year: 1991 Document type: Article Country of publication: Netherlands
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Poxviridae / Rabies / Rabies virus / Viral Vaccines Limits: Animals Language: En Journal: Vaccine Year: 1991 Document type: Article Country of publication: Netherlands